Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fresenius acquires Hema Metrics' Crit-Line monitoring products

This article was originally published in Clinica

Executive Summary

Dialysis specialist Fresenius Medical Care has acquired Hema Metrics’ Crit-Line system, a noninvasive patient monitoring tool. The deal, which is already closed, is worth up to $25m; $12m was paid upfront and the remainder will be paid as milestones between now and 2016. The device uses photo-optical technology to measure blood parameters including haematocrit, percent blood volume change, and continuous oxygen saturation; monitoring these can help clinicians improve fluid management during haemodialysis and manage anaemia. Bad Homburg, Germany-based Fresenius described the technology as an “excellent fit” with its 2008K, 2008K2 and 2008T dialysis machines, and hopes to make Crit-Line the standard of care for fluid and anaemia management in North America. Crit-Line received 510(k) clearance from the US FDA in October 2010, and is also CE marked for sale in Europe. Chronic kidney failure affects about 1.9 million people worldwide.

You may also be interested in...



What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.

Topics

UsernamePublicRestriction

Register

LL1134940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel